google.com, pub-8701563775261122, DIRECT, f08c47fec0942fa0
USA

3 Giant Dividend Stocks to Buy to Shield Your Portfolio Now

Division and Dollar by Markgrafave via Istock

During market volatility and economic uncertainty, investors generally take refuge in stocks that pay dividends. These rare giants are not only consistent income, but also provide long -term stability.

Dividend giants are typically well -established companies with a long rewarding shareholder history that can help protect your portfolio.

ABBVIE (ABBV), worth approximately $ 328 billion, is a US -based biofarmautic company that focuses on treating autoimmune disorders, cancers, neurological conditions and aesthetic medical needs. Strong cash flow, innovative research and various portfolio of leading drugs position it as a global leader in prescription therapeutics and aesthetics.

Abbvie has an advanced dividend return of 3.5%, which is higher than 1.58%than the average of the health sector. Although the yield is attractive, a reasonable payment rate shows how much of the company’s net income as a dividend when the company allocates enough to re -invest. The advanced payment rate is relatively low by 46.9%, which indicates that dividend payments are sustainable and a place to grow. Abbvie is also a king who paid dividends for 53 years.

ABBVIE is known for Humira, which breaks box office records that treat autoimmune diseases such as rheumatoid arthritis, Crohn’s disease and psoriasis. However, in order to deal with Humira’s end of the patent, the company expanded its portfolio to include box office records such as Skyrizi (for Sedef and Crohn’s) and Rinvoq (for rheumatoid arthritis and ulcerative colitis).

In the last quarter, Skyrizi’s sales increased by 70.5%, $ 3.4 billion, while rinvoqs increased by 57.2%to $ 1.7 billion. Corrected earnings increased by 6.5% in the quarter.

In general, Wall Street gave the Abbvie stock a “moderate purchase” note. 14 of the 27 analysts covering stocks have a degree of “strong purchasing ,, two suggests the“ moderate purchase ”grade and 11“ waiting ”note. The average target price for ABBV is $ 208.88, which is over 10% of its current levels. The high price estimate of $ 250 means a potential increase of 33% over the next 12 months.

The screenshot of the content created by the computer AI may be wrong.
www.barchart.com

AT&T (T) is a large American telecommunication company with a market value of 208 billion dollars. It provides business and corporate solutions such as wireless services, internet and wide band services, TV and flow services, as well as network connection, cyber security and cloud services.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also
Close
Back to top button